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Abstract 
Background 
Systematic reviews of randomized controlled trials (RCTs) have suggested that maternal 
vitamin D (25(OH)D) and calcium supplementation increase birth weight. However, 
limitations of many trials were highlighted in the reviews. Our aim was to combine genetic 
and RCT data to estimate causal effects of these two maternal traits on offspring birth weight. 
Methods and Findings 
We performed two-sample Mendelian randomisation (MR) using genetic instrumental 
variables associated with 25(OH)D and calcium that had been identified in genome wide 
association studies (GWAS; sample 1; N = 122,123 for 25(OH)D and N= 61,275 for 
calcium). Associations between these maternal genetic variants and offspring birth weight 
were calculated in the UK Biobank (UKB) (sample 2; N=190,406). We used data on mother-
child pairs from two UK birth cohorts (combined N=5,223) in sensitivity analyses to check 
whether results were influenced by fetal genotype, which is correlated with the maternal 
genotype (r≈0.5). Further sensitivity analyses to test the reliability of the results included 
MR-Egger, weighted-median estimator, “leave-one-out” and multivariable MR analyses. We 
triangulated MR results with those from RCTs, in which we used randomisation to 
supplementation with vitamin D (24 RCTs, combined N=5,276) and calcium (6 RCTs, 
combined N=543) as an instrumental variable to determine the effects of 25(OH)D and 
calcium on birth weight.  
In the main MR analysis, there was no strong evidence of an effect of maternal 25(OH)D on 
birth weight (difference in mean birth weight -0.03g (95%CI: -2.48 to 2.42g, p=0.981) per 
10% higher maternal 25(OH)D). The effect estimate was consistent across our MR sensitivity 
analyses. Instrumental variable analyses applied to RCTs suggested a weak positive causal 
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effect (5.94g (95% CI: 2.15 to 9.73, p=0.002) per 10% higher maternal 25(OH)D), but this 
result may be exaggerated due to risk of bias in the included RCTs. The main MR analysis 
for maternal calcium also suggested no strong evidence of an effect on birth weight (-20g 
(95%CI: -44 to 5g, p=0.116) per 1 SD higher maternal calcium level). Some sensitivity 
analyses suggested that the genetic instrument for calcium was associated with birth weight 
via exposures that are independent of calcium levels (horizontal pleiotropy). Application of 
instrumental variable analyses to RCTs suggested that calcium has a substantial effect on 
birth weight (178g (95% CI 121 to 236g, p=1.43 x 10-9) per 1 SD higher maternal calcium 
level) that was not consistent with any of the MR results. However, the RCT instrumental 
variable estimate may have been exaggerated owing to risk of bias in the included RCTs. 
Other study limitations include the low response rate of UK Biobank, which may bias MR 
estimates, and the lack of suitable data to test whether the effects of genetic instruments on 
maternal calcium levels during pregnancy were the same as those outside of pregnancy.  
Conclusions 
Our results suggest that maternal circulating 25[OH]D does not influence birth weight in 
otherwise healthy newborns. However, the effect of maternal circulating calcium on birth 
weight is unclear and requires further exploration with more research including RCT and/or 
MR analyses with more valid instruments. 
Author Summary 
Why Was This Study Done? 
 Birth weight that is lower or higher than average has been associated with poor health 
outcomes across the lifespan, including infant mortality, cardiovascular disease and 
type 2 diabetes. 
4 
 
 If we can identify modifiable maternal factors in pregnancy that are causally related to 
birth weight, we may be able to reduce the number of babies that are born with lower 
or higher than optimal birth weight. This may in turn help to reduce the associated 
poor health outcomes. 
 Previous studies have suggested that higher maternal 25(OH)D and calcium in 
pregnancy are associated with higher birth weight. However many of those studies 
used conventional multivariable regression in observational studies and may be 
subject to residual confounding. Few of them estimated the size of the effect of either 
maternal 25(OH)D or calcium levels on birth weight. 
What Did the Researchers Do and Find? 
 We estimated the effects of maternal gestational 25(OH)D and calcium levels on 
offspring birth weight using Mendelian Randomization, a method that uses genetic 
data to overcome certain limitations of traditional observational studies, for example 
residual confounding. 
 We analysed genetic data on 190,406 women from the UK Biobank who reported the 
birth weight of their first child, along with the results from published studies of 
genetic associations with 25(OH)D and calcium levels in 122,123 and 61,275 
individuals, respectively. 
 We checked that the results were not biased by offspring genotype using data from 
two UK Birth cohorts, the ALSPAC (n=4,576 mother-child pairs) and EFSOCH 
studies (n=647 mother-child pairs), respectively. 
 To strengthen our causal understanding, we triangulated the Mendelian randomization 
results with findings from randomised controlled trials in which we used randomised 
status (to vitamin D or calcium supplementation) as an instrumental variable to 
estimate the effect of 25(OH)D or calcium on birth weight. 
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 We found no evidence of a strong effect of maternal 25(OH)D on birth weight. 
 We found inconsistent evidence of effects of maternal calcium on birth weight.   
What Do These Findings Mean? 
 Our findings do not support using vitamin D supplementation during pregnancy or 
pre-conceptually to influence offspring birth weight. 
 The effect of calcium on birth weight is still unclear, and needs further investigation 
in well powered genetic studies and/or well-conducted randomised controlled trials.  
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Introduction 
Infants with lower or higher birth weight (BW) than average are at an increased risk of 
neonatal mortality and morbidity [1]. BW is also inversely associated with some adverse 
adult health outcomes, including coronary heart disease[2], type 2 diabetes[3], poor cognitive 
ability[4] and several types of cancer[5], with most of these associations being linear across 
most of the BW distribution. BW is an indicator of conditions in utero and may be influenced 
by modifiable factors in the maternal circulation. For example, there is evidence that higher 
maternal fasting glucose is causally related to greater fetal growth and higher BW[6,7], which 
increases the risk of complications during delivery. However relatively little is known about 
the causal influences of other maternal factors. More evidence is required on how modifying 
the in utero environment might influence BW and associated health outcomes.  
Maternal gestational circulating 25(OH)D[8] and calcium[9] may be modifiable risk factors 
that impact fetal growth and hence BW. Several observational studies using conventional 
multivariable regression analyses suggest positive associations of maternal 25(OH)D and 
calcium with infant BW[10-13], however these results might be explained by residual 
confounding. Systematic reviews of randomised controlled trials (RCTs) of gestational 
supplementation with vitamin D[14] or calcium[15] have suggested that this supplementation 
increases BW. However, the authors of the latest vitamin D supplementation systematic 
review concluded that most of the trials were small and of low quality, and the difference in 
mean BW was small and unlikely to be of clinical or public health importance[16]. For the 
calcium supplementation systematic review, the authors noted that for most of the trials there 
was a low risk of bias based on a score that did not include intention to treat as one of the risk 
of bias criteria. However, there were high levels of heterogeneity in the results between the 
trials, bringing into question the clinical importance of calcium supplementation on BW[15]. 
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Mendelian randomisation (MR) is a method in which genetic variants associated with a 
modifiable exposure are used as instrumental variables to estimate the causal effect of the 
exposure on an outcome[17]. As genetic variants are fixed at conception, and are generally 
not associated with classical confounders, MR is less susceptible to bias resulting from 
reverse causation and residual confounding [17]. We have previously performed a MR study 
on the effects of maternal adiposity related exposures on BW, finding a positive effect of 
body mass index (BMI) and blood glucose and an inverse causal effect of systolic blood 
pressure on BW[6]. In that study, there was evidence of a possible positive causal effect of 
25(OH)D on BW, however the confidence intervals were wide and included the null value[6]. 
A possible causal association of maternal circulating calcium with infant BW was not 
explored in that study, and to the best of our knowledge there have been no MR studies of 
that association. The aim of this study was to use MR to explore whether there are causal 
effects of maternal circulating 25(OH)D and calcium on BW, and if so what the magnitude 
those effects are. With the release of new UK Biobank data[18], we have a substantially 
increased the sample size in comparison to the earlier MR study of  25(OH)D, as well as 
having access to more genetic instruments for 25(OH)D[19], both of which will increase 
statistical power and hence effect estimate precision. We complement our MR analyses by 
triangulating results with findings from instrumental variable analyses applied to RCTs of 
supplementation with vitamin D or calcium[20]. 
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Methods 
The analyses plan was developed by RMF, DAL, WDT and MCB, prior to any analyses 
beginning. It was acted on by WDT and MCB. The analysis plan has not been published but 
was informally recorded in meeting notes. We made one change to the overall study plans 
after completing analyses; we undertook risk of bias assessment of the RCTs with a focus on 
factors that might mean instrumental variable assumptions were violated. This was motivated 
by differences in results comparing MR to instrumental variables in RCTs, particularly in 
relation to the effects of calcium on BW. We made one change to the plan following 
reviewer’s comments; we undertook two multivariable MR analyses to adjust for potential 
confounders. These were: (i) multivariable MR of the association of 25(OH)D with BW 
adjusting (genetically) for maternal height and (ii) partial multivariable MR of the association 
of calcium with BW adjusting (genetically) for maternal educational level.  
The study design and different data sources are summarized in Fig 1, with Table 1, S1 Text, 
S2 Text, S3 Text, S4 Text, S1 Table, S2 Table, S3 Table, S4 Table and S1 Fig, S2 Fig and 
S3 Fig providing more data on each study that has contributed to this paper. Further details, 
including details of participant consent and ethics approvals, are described in the 
supplementary material methods. Ethical approval for data extraction from all of the cohorts 
used in this study was granted from the appropriate authorities (for more details, see S1 
Text). This study is reported according to the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) guideline (S1 Checklist). 
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Figure 1: Summary of methods and data contributing to this study 
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Table 1: Characteristics of the studies used to obtain 25(OH)D/calcium SNPs (genetic instrumental variables) effects on offspring birth weight 
 Study Average/Typical value of Study 
Country UK Biobank United Kingdom 
ALSPAC United Kingdom 
EFSOCH United Kingdom 
Offspring years of birth UK Biobank 1954-2011 
ALSPAC 1991-1993 
EFSOCH 2000-2004 
Number of Participants UK Biobank 190,406 
ALSPAC 4576 
EFSOCH 647 
Maternal Age (years) UK Biobank 25.9 (5.0) 
ALSPAC 29.0 (4.6) 
EFSOCH 30.4 (5.2) 
Maternal BMI (kg/m2) UK Biobank 27.07 (5.03) 
ALSPAC 22.91 (3.72) 
EFSOCH 24.03 (4.32) 
Maternal height (cm) UK Biobank 162.5 (6.1) 
ALSPAC 164.5 (6.7) 
EFSOCH 165.0 (6.3) 
Birth weight (g) UK Biobank 3227 (476) 
ALSPAC 3495 (471) 
EFSOCH 3514 (475) 
Gestational age 
(weeks) 
UK Biobank NA 
ALSPAC 39.8 (1.3) 
EFSOCH 40.1 (1.2) 
Offspring sex (% male) UK Biobank NA 
ALSPAC 49 
EFSOCH 52 
UK Biobank 141 (24) 
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Maternal Systolic Blood Pressure 
(mmHg) 
ALSPAC 133 (13) 
EFSOCH NA 
Mothers smoking (%)a UK Biobank 12 
ALSPAC 15 
EFSOCH 14 
Townsend Deprivation Indexb UK Biobank -1.66 (2.86) 
ALSPAC NA 
EFSOCH 0.23 (3.29) 
Educational Attainment: mothers 
with a university degree (%) 
UK Biobank 47 
ALSPAC 14 
EFSOCH NA 
Western Dietc (SD) UK Biobank -0.087 (0.98) 
ALSPAC NA 
EFSOCH NA 
Age of assessment for age of first 
birth (years) 
UK Biobank 58.0 (7.8) 
ALSPAC NA 
EFSOCH NA 
a) In ALSPAC and EFSOCH this is the percentage of women who smoked during pregnancy, for UKB it is the percentage of women who 
smoke. 
b) An area deprivation index that takes summary data on deprivation measures from the census for a defined small geographical area (percentage 
of households without a motor vehicle, percentage of households with more than one person per room, percentage of households not owner-
occupied and percentage of residents who are unemployed), converts them to standard deviation scores across all areas of the UK, then sums 
them to give a relative area deprivation value, such that a higher score indicates greater deprivation for the area compared to the UK as a 
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whole[21], in UKB these reflect adult area of residence deprivation based on the postcode provided by the participants at their baseline 
assessment (aged 40-60 years).  
c) Western Diet is a principal component of variation in reported diet in UK Biobank. Variation in diet was measured using a dietary 
questionnaire[22].  
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Mendelian Randomisation 
We used two-sample summary data MR to explore the effect of maternal circulating vitamin 
D (25(OH)D) and calcium levels on offspring BW[23]. We used (i) summary data from 
published genome-wide association studies (GWAS) for the associations of genetic variants 
(single nucleotide polymorphisms, or SNPs) with 25(OH)D[19,24] or calcium[25] (sample 1) 
and (ii) summary data for the associations of SNPs with BW from UK Biobank (UKB)[18] 
(sample 2). Summary data from two UK birth cohorts, the Avon Longitudinal Study of 
Parents and Children (ALSPAC)[26] and Exeter Family Study of Childhood Health 
(EFSOCH)[27] were generated for use in sensitivity analyses to explore bias due to fetal 
genotype. In all studies we excluded participants of non-White European origin (S2 Text 
describes how ethnicity was defined in each study). Following these exclusions we included 
190,406 women from UKB who had valid data on BW of first child and GWAS data, 4,576 
mother-offspring pairs from ALSPAC and 647 mother-offspring pairs from EFSOCH who all 
had offspring BW and maternal and offspring GWAS data . 
Birth weight and serum 25(OH)D measurement 
The UKB is a study of 502,655 participants[28]. Female participants (N=273,495) were also 
asked to report the BW of their first child. Female participants that reported having a multiple 
first birth were excluded from our analyses (N=1,364). A total of 216,839 women with a 
singleton pregnancy for their first child, reported the BW of their first child. Values were 
reported to the nearest whole pounds, and were converted to kilograms, by multiplying by 
0.454, for our analyses. Where women reported the BW of the first child at multiple time 
points (N=11,353) we used the mean of all measures after excluding any women with a 
difference of >1kg between any two measures (N=31). We further excluded from the whole 
sample any women who reported the BW of their first child <2.2kg or >4.6kg (N=6,333). 
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This was done to reduce bias from reporting errors and, in relation to those <2.2kg to exclude 
extreme preterm births given we do not have information on gestational age. BW of first 
child was regressed against the women’s reported age at first birth and her UKB assessment 
centre location to reduce heterogeneity in reporting bias by these characteristics. Residuals 
from that regression model were then standardized to a mean of 0 and an SD of 1, with the 
standardized residuals being used in all analyses and final results converted back to grams. 
The analyses were done on standardized residuals to reduce the amount of computing power 
needed when doing the initial genome wide association analyses, and so the summary GWAS 
data that we used for our main analyses was already in this standardized format. UKB 
participants’ (women and men) reports of their own birth weights were used in sensitivity 
analyses described below and similar methods of exclusion and use of standardized (on age at 
assessment and centre) residuals, with conversion of results back to grams were used for own 
BW (see S3 Text for further details). 
In ALSPAC and EFSOCH, BW was extracted (in grams) from obstetric clinical records at 
the time of birth, which occurred between 1991 and 1992 (mean (SD) age of mothers 29 (4.6) 
years) in ALSPAC[26], and between 2000 and 2004 (mean age of mothers 30.4 (5.2) years)in 
EFSOCH[27]. 
The GWAS of 25(OH)D and calcium, that we have used in our MR analyses, were 
undertaken on adult European origin (non-pregnant) women and men. Our MR analyses 
assume that the magnitude of gene instrument variable-25(OH)D (or calcium) association 
from those studies are the same in women during pregnancy. We were able to test this for 
25(OH)D in ALSPAC, in which 25(OH)D was measured during pregnancy in mothers, using 
methods that have previously been reported[29] (see S4 Text). Neither 25(OH)D nor calcium 
were measured during pregnancy in UKB or EFSOCH; calcium was not measured in 
ALSPAC. 
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Genotyping 
For UKB, we analysed data from the May 2017 release of imputed genetic data which has 
been extensively described elsewhere[30]. Given the reported technical error with non-HRC 
imputed variants[31], we focused exclusively on the set of ~40M imputed variants from the 
HRC reference panel.  
To account for population structure and relatedness a linear mixed model implemented in 
BOLT-LMM v2.3[32] was used to perform genome-wide association (GWA) analysis of BW 
in the UKB sample. Only autosomal single nucleotide polymorphisms (SNPs) which were 
common (MAF>1%), in Hardy Weinberg equilibrium (p value > 1x10-6), passed QC in all 
106 batches and were present on both genotyping arrays were included in the genetic 
relationship matrix (GRM). For the GWA analyses of BW of the first child (i.e. using the 
maternal genotype), the genotyping array and genotyping release (interim vs. full) were 
included as covariates in the regression model. For the GWAS of participants own BW (see 
below under exploring violation of MR assumptions for the rationale behind these analyses), 
genotyping array, age at baseline and sex were adjusted for in all models. 
In both ALSPAC and EFSOCH, the SNPs used in this study (see below) were taken from 
genome-wide imputed data that had been completed for both the mothers and their offspring 
(fetal genotype). In ALSPAC maternal data was obtained from the Illumina 610 Quad Array 
and fetal data was obtained from the Illumina 550 Quad Array. In EFSOCH maternal and 
fetal data were obtained from the Illumina Infinium HumanCoreExome-24. For both 
ALSPAC and EFSOCH, genotype data were imputed against Haplotype Reference 
Consortium HRC v1.1 reference panel after quality control (MAF >1%, HWE>1×10-6, sex 
mismatch, kinship errors and 4.56 SD from the cluster mean of any sub-populations 
cluster)[26,33]. 
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SNP selection, and summary data for SNP-25(OH)D and SNP-calcium associations 
We searched for the largest well-conducted GWAS to identify genetic variants (SNPs) that 
could be used as instrumental variables for circulating 25(OH)D and calcium, and to obtain 
summary data of genetic instrumental variable (SNP) associations with 25(OH)D and 
calcium for use in our two-sample MR.  
For 25(OH)D, we used summary association results for SNPs identified in two 
GWAS[19,24], with the largest of these including 79,366 participants from 31 studies in 
discovery analyses and 42,757 participants from 2 studies in replication analyses. In our main 
analyses we used seven SNPs, which were not in linkage disequilibrium, from either of the 
GWAS that had a p-value of 5×10-8 in discovery analyses and were replicated. Two of the 
SNPs discovered in the largest GWAS (rs3755967 and rs17216707) were different from, but 
in the same loci as, two SNPs identified in an earlier, more commonly used GWAS 
(rs2282679 and rs6013897, respectively)[34]  that have been commonly used as instruments 
of 25(OH)D in previous MR analyses. We measured linkage disequilibrium between these 
SNPs in White Europeans (CEU) using LDLink[35,36], and found that both were >0.5, 
suggesting the SNPs in each pair are tagging the same variant. In additional analyses we 
separately conducted two analyses with genetic instruments hypothesized to be involved in 
25(OH)D synthesis (three SNPs) and 25(OH)D metabolism (two SNPs)[37].   
For calcium, we used summary association results for SNPs identified in a GWAS of 39,400 
participants [25] from 19 studies in discovery analyses and 21,875 participants from 11 
studies as replication. We used seven SNPs, which were not in linkage disequilibrium, that 
were associated with calcium levels at a p-value of 5×10-8 in discovery analysis and were 
replicated.  
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Further details of the 25(OH)D and calcium GWAS are provided in S1 Table, and a list of 
the SNPs used in our MR analyses, together with their allele frequencies and per allele 
associations, for 25(OH)D and calcium are provided in S2 Table. 
For UKB, the summary results of associations between SNPs and first child BW (maternal 
genotype) or own BW (own genotype) were extracted from the GWAS results (see above for 
details on how each GWAS was conducted). For ALSPAC and EFSOCH, individual level 
SNP data was extracted and summary data were generated using multivariate linear 
regression of the SNPs against BW (adjusting for gestational age and the child’s sex). 
To make sure that the outcome data (BW) and exposure data (25(OH)D and calcium) were 
comparable, the SNPs effects were harmonized to the 25(OH)D/calcium raising alleles using 
procedures that have previously been described[38].  
Statistical Analysis 
The main and sensitivity two-sample MR methods are summarized in Table 2. In all analyses 
we estimated the effect of a 10% increase in 25(OH)D on BW in grams, and the effect of 1 
SD  increase in calcium on BW in grams; these units reflecting the units of 25(OH)D and 
calcium used in the published GWAS. The value of a 10% increase in 25(OH)D will vary 
depending on the ‘starting point’. In the gestational measures of 25(OH)D in ALSPAC, the 
median level of 25(OH)D is 61.8 nmol/l, the 25th percentile is 46.1 nmol/l and the 75th 
percentile is 81.6 nmol/l; this makes a 10% increase from these points equivalent to 6.2 
nmol/l, 4.6 nmol/l and 8.2 nmol/l respectively. The accepted range of calcium in a healthy 
population is between 8.5 mg/dl and 10.5 mg/dl[39], and dividing that range by four we 
estimated that the SD of calcium is 0.5 mg/dl (~0.3mmol/l). 
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Table 2: Summary of the four methods used for MR analysis 
Name of method Wald Ratio (meta-
analysis)[40] 
Inverse-Variance 
Weighted[41] 
MR-Egger[41] weighted-median[42] 
Assumption There is no unbalanced 
horizontal pleiotropy.  
There is no unbalanced 
horizontal pleiotropy. 
That the effect of the genetic 
instrument is not correlated 
with any pleiotropic effect of 
the instrument on the 
outcome. 
Less than 50% of the 
weight in the analyses 
come from invalid 
instruments.  
Equation 𝑊𝑎𝑙𝑑 𝑅𝑎𝑡𝑖𝑜 =  
𝛽𝑦|𝑧
𝛽𝑥|𝑧
  𝛽𝐼𝑉𝑊=
∑ 𝐸𝑗
2𝜎𝑒𝑗
−2𝛽𝑗
𝐽
𝑗=1
∑ 𝐸𝑗
2𝐽
𝑗=1 𝜎𝑒𝑗
−2   
𝛽𝑀𝑅 =
𝜌𝑗−𝛽0
𝐸𝑗
  𝜌𝑗 = 100(𝑆𝑗 −  
𝑤𝑗
2
)  
Notes on Equation βy|z is the SNPs effect on 
the outcome and βx|z is the 
SNPs effect on the 
exposure. Wald ratios for 
each SNP were pooled 
using fixed-effect meta-
analysis with inverse 
variance weights  
βj is the ratio method estimate 
for each genetic instrument, 
σej-2 is the standard error of 
the genetic variants effect on 
outcome and Ej2 is the 
genetic instruments effect on 
the exposure. 
β0 is the intercept, Ej is the 
genetic instruments effect on 
the exposure and ρj is the 
genetic instruments effect on 
the outcome.   
Multiple ratio estimates, or 
βj, are calculated and the 
median percentile value is 
chosen. Importantly, each 
percentile value is 
weighted. Sj is the sum of 
the weights up to the given 
genetic instrument, ρj is the 
percentile value, and wj is 
the weight given to the 
genetic instrument. 
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The main effects were calculated in all three studies (UKB, ALSPAC and EFSOCH) using 
two methods; fixed-effect meta-analysis of Wald ratios[40] of the seven SNPs for 25(OH)D 
or the seven SNPs for calcium; and the inverse-variance-weighted (IVW) instrumental 
variable method[41] (Table 2).. 
Wald ratios were calculated by dividing each SNP’s effect on BW by the same SNP’s effect 
on the exposure (25(OH)D or calcium). Standard errors were calculated by dividing the 
standard error of the SNP’s effect on BW by each SNP’s effect on the exposure. The ratios 
for each SNP were then pooled using fixed effect meta-analysis. I2 and leave-one-out analysis 
were used to explore between SNP heterogeneity in their MR results (which if present may 
be due to one or more of the SNPs being an invalid instrumental variable)[43]. 
For the IVW analysis, linear regression of the weighted (by inverse of their variance) SNPs 
associations with BW against the SNPs association with maternal circulating 25(OH)D or 
calcium were performed[41]. In IVW regression analyses, the intercept is forced through 
zero, making the regression coefficient comparable to the pooled Wald ratio effect estimate. 
In the presence of heterogeneity, standard errors are larger for IVW compared to pooled 
Wald ratios. For our analysis we estimated standard errors using a fixed effects model and 
confidence intervals using a t-distribution. 
Exploring possible violations of MR assumptions 
Both the Wald ratio method and IVW instrumental variable analysis assume that: (i) that the 
SNPs being used are robustly associated with maternal circulating 25(OH)D and calcium; ii) 
the SNPs are not related to confounders of the associations 25(OH)D and/or calcium with 
BW; and (iii) the SNPs have no effect on BW other than through 25(OH)D and calcium (also 
known as the exclusion restriction criterion). In MR studies horizontal pleiotropy is a 
common cause of violation of this assumption. This would occur if our genetic instrument for 
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25(OH)D or calcium influenced other factors, separately to 25(OH)D or calcium, and these 
other factors influence birth weight independently of 25(OH)D or calcium. If this were the 
case, then then estimate of effect that we assumed was due to e.g. 25(OH)D would be the sum 
of a 25(OH)D effect and the effect on the outcome of any other (pleiotropic) effects. The 
Wald ratio and IVW approaches complement each other, with determining Wald ratios for 
each SNP providing an opportunity to explore between SNP heterogeneity and IVW being 
closely related and comparable to one of our sensitivity analyses (MR-Egger) used to test 
possible horizontal pleiotropy (Table 2). 
One possible source of bias is via the fetal genotype[44]. Maternal genetic variants that 
influence 25(OH)D and calcium will be associated with the distributions of the same genetic 
variants in the fetus (as mothers may transmit these alleles to their offspring), and if any of 
these genetic variants affect fetal growth independently of an effect of maternal circulating 
25(OH)D/calcium (for example if fetal 25(OH)D or calcium influence fetal growth), there 
will be an association between maternal SNPs and offspring BW that is not via the mother’s 
gestational 25(OH)D or calcium. We tested this possible source of bias in two ways. First, we 
adjusted the maternal SNP with offspring BW association for fetal genotype in a total of 
5,223 genotyped mother-child pairs from the ALSPAC and EFSOCH studies. The Wald ratio 
results were estimated separately for each of these two cohorts and then pooled using a fixed-
effect meta-analysis. Second, we used IVW to estimate the effect of own 25(OH)D or 
calcium on own BW (with a total of 215,444 adult women and men reporting their own BW) 
in UKB, for comparison with the effect estimates of maternal 25(OH)D or calcium on 
offspring BW. Stronger effects of own (fetal) 25(OH)D/calcium on their BW (compared with 
maternal gestational circulating levels of these on offspring BW) would suggest the 
possibility of our main MR analyses of maternal 25(OH)D/calcium levels on offspring BW 
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being biased by fetal effects (assuming that measurement error in offspring BW and own BW 
are similar). 
We performed three additional tests to investigate possible violations of MR assumptions: 
MR-Egger[41] and weighted-median estimator[42], which were only used in UKB (which we 
considered our main analysis cohort and which has adequate statistical power for these 
analyses), and exploring SNP associations with confounders in UKB, ALSPAC and 
EFSOCH (further details of these approaches are provided in S5 Text). 
Instrumental variable analysis applied to RCTs 
Instrumental variable methods can be applied to RCTs to quantify the causal effect estimate 
of the intermediate that the randomised treatment is assumed to influence[45]. For example, 
here we used RCTs of randomisation to vitamin D supplements to quantify the effect of 
circulating 25(OH)D on birth weight. This differs from the original aim and analyses of these 
RCTs which was to determine the causal effect of the supplements. These analyses are 
similar to Mendelian randomization, except here the instrumental variable is randomized 
status. This approach has the same underlying assumptions as all instrumental variable 
analyses, including MR. However, we assume that they key sources of violation of these 
assumptions will differ between the RCT and MR analyses (e.g. in the RCTs concealment of 
randomization and intention to treat analyses will be important, whereas in MR horizontal 
pleiotropy due to linkage disequilibrium will be important). Under this assumption, if results 
from our MR and RCT analyses are consistent with each other this increases the likelihood 
that this is the correct causal effect[20]. 
We used data from recent systematic reviews and meta-analyses of supplements versus 
placebo, in pregnant women, for both 25(OH)D[16] and calcium[15] to identify individual 
RCTs that could be used in our instrumental variable analyses applied to RCTs. As different 
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RCTs used different doses, type of supplement (e.g. vitamin D2 or D3) or mode of delivery 
(e.g. oral or injection), and because to date relatively little work has used instrumental 
variables in RCTs to test causal effects, we a priori decided we would use a one-sample 
instrumental variable approach and only include RCTs that provided both the difference in 
mean BW and difference in mean 25(OH)D/calcium by randomized arm. Each individual 
RCT in both reviews was searched to identify those that provided difference in mean BW and 
25(OH)D/calcium. This resulted in us being able to include 24 (56%) out of 43 RCTs from 
the most recent pregnancy vitamin D supplementation systematic review (published 2017) 
and 6 (26 %) out of 23 RCTs included in the most recent calcium supplementation systematic 
review (2015); all other RCTs had either no information on differences in mean BW or 
differences in mean 25(OH)D/calcium. 
Two of the authors (WDT and DAL) independently extracted the weighted mean differences 
in 25(OH)D and BW by trial randomised arm (25(OH)D supplement or placebo/other 
control), together with their respective confidence interval values, from 24 RCTs that 
presented results for both of these (N = 5,276 mother-offspring pairs)[16] (S3 Table). 
Similarly, for calcium two authors (WDT and M-CB) independently extracted mean 
differences and confidence intervals for 6 RCTs (543 mother offspring-pairs)[15] (S4 Table). 
Standard errors were calculated by each of the independent abstractors and a third author 
(RMF), checked consistency between the abstractors with any discrepancy resolved by 
discussion between four authors, WDT, DAL, M-CB and RMF. One of the calcium 
RCTs[46] provided a range of the mean difference, which we treated as the 95% confidence 
intervals when calculating the standard error.  
We calculated the Wald ratio estimate for each RCT by dividing the difference in mean BW 
by the difference in mean 25(OH)D (or calcium) and then pooled the these using a fixed 
effect meta-analysis and tested for between study heterogeneity using the I2 statistic and 
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leave-one-out-analysis. For the vitamin D supplementation RCTs differences in mean 
25(OH)D were in nmol/l and for the calcium supplementation RCTs differences in mean 
calcium were in mg/dl. In order to make the instrumental variable analyses in RCT results 
comparable with our two-sample MR results, for 25(OH)D we assumed that a 10% difference 
was equivalent to 6.2 nmol/l (the value for a 10% difference around the median of the 
distribution of pregnancy 25(OH)D in ALSPAC), and we multiplied the Wald ratio estimates 
by 6.2 to scale the results so that they represented the difference in mean BW per 10% 
increase in 25(OH)D. We did the same with calcium, but used 0.5 (0.5 mg/dl being the 1 SD 
difference value used in our MR analysis) to scale results so that they represented the 
difference in mean birth weight per 1SD of calcium.  
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Results  
The characteristics of included participants from UKB, ALSPAC and EFSOCH are shown in 
Table 1. The SNP-outcome associations for UKB, ALSPAC and EFSOCH are shown in S5 
Table, S6 Table and S7 Table.  
Mendelian randomisation and instrumental variable analysis in RCTs do not support a 
clinically important effect of 25(OH)D on birth weight 
Our two-sample MR results provide no strong evidence of an effect of maternal circulating 
25(OH)D on offspring BW, with consistent null findings in the main Wald ratio and IVW 
analyses, and also with the MR-Egger and weighted median results using the UKB data (Fig 
2). There was no strong evidence for marked heterogeneity between the Wald ratio estimates 
for each SNP (I2 = 0.0%) and results were consistent in leave one out analysis with the main 
results (i.e. no SNPs removed) and with each other (S4 Fig). MR effects in ALSPAC and 
EFSOCH were weakly positive but with wide confidence intervals that included the null 
value (Fig 2). The effect estimates were the same with and without adjustment for fetal 
genotype in ALSPAC and EFSOCH, and there was no strong evidence that own 25(OH)D 
influenced own BW in UKB (Fig 2). Our main MR effect estimate in UKB was -0.03g (95% 
CI, -2.48 to 2.42g, p=0.981) per 10% increase in maternal circulating 25(OH)D. However, 
the RCT instrumental variable effect was 5.94g (95% CI, 2.15 to 9.73, p=0.002) per 10% 
increase in maternal circulating 25(OH)D) (Fig 2). There was no strong evidence for marked 
heterogeneity between the instrumental variable in RCT estimates (I2=16.2%) and results 
were consistent, with the main overall result, and with each other, in leave one out analysis 
(S5 Fig).
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Figure 2: Causative effect estimates for maternal 25(OH)D on birth weight 
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The difference between the MR and instrumental variable analyses in RCTs is small, and the 
confidence intervals for the two results overlap, suggesting that they are statistically 
consistent. To explore this small difference further we undertook post hoc risk of bias 
assessment of the 24 RCTs. S8 Table summarises the results of this risk of bias assessment. 
Most studies were small, with the numbers randomised being between 16 and 1134 and only 
three of the 24 RCTs including more than 200 participants. Where it was reported (16 of the 
24 trials) loss to follow-up ranged from 1 to 31%. Only two of the RCTs (12% of 
participants) had definitely undertaken intention to treat analyses and twelve (54% of studies) 
had used random sequence and concealed allocation to treatment groups. 
Though there were only a small number of genetic instruments, and thus limited ability to test 
potential biases from horizontal pleiotropy and weak instruments, there was no strong 
evidence that 25(OH)D synthesis or metabolism had an effect on BW (S6 Fig).   
Mendelian randomisation and instrumental variable analyses applied to RCTs give 
conflicting results on the effect of calcium on birth weight 
Our main two-sample MR results provide no strong evidence of an effect of maternal 
circulating calcium on offspring BW, with consistent null findings across the Wald ratio, 
IVW and weighted median results using UKB. However, there was evidence of horizontal 
pleiotropy, with the MR-Egger intercept being -2g (95% CI, -4 to -0.5g, p=0.025) and the 
effect estimate suggesting a possible modest effect of 41g (95% CI, -18 to 100g, p=0.132) 
per 1SD increase in maternal circulating calcium, compared to the weak inverse effect in the 
IVW and Wald ratio estimates of -20g (95% CI, -44 to 5g, p=0.116) (Fig 3). There was also 
evidence for heterogeneity between the Wald ratio estimates for each SNP (I2 =62.4%), and 
removing one of the SNPs (rs1801725) strengthened the inverse effect estimate to -61g (95% 
CI, -99 to -23g, p=0.002) per 1SD increase in maternal circulating calcium, with removal of 
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the other six SNPs resulting in estimates close to the main result and consistent with each 
other (S7 Fig). The Wald ratio for only the rs1801725 SNP was 10g (95% CI, -22 to 41g, 
p=0.558) per 1 SD increase in maternal circulating calcium. There was no evidence that fetal 
genotype influenced the results, as results were similar with or without adjustment for it, and 
the IVW analyses for adults own BW gave a similar result to the IVW analyses for first 
child’s BW (Fig 3). The RCT instrumental variable effect on calcium suggested a strong 
positive effect that was inconsistent with any of the MR estimates (including MR-Egger): 
178g (95% CI, 121 to 236g, p=1.43 x 10-9) change in BW per 1SD increase in maternal 
circulating calcium (Fig 3). There was no strong evidence for heterogeneity between the RCT 
instrumental variable results (I2= 0.0%), but the main result and leave one out analyses had 
wide confidence intervals (S8 Fig). Given the marked difference in the instrumental variable 
results in RCTs compared with any of the MR analyses we (post hoc) looked for potential 
bias within the specific RCTs that we were able to include in our one-sample instrumental 
variable analyses of calcium on BW. Of the six included RCTs, three had fewer than 100 
participants (Ns = 23 to 72), and the two largest RCTs (N = 120 and 274), together with two 
other studies, did not use intention to treat analysis (S9 Table), which could result in biased 
effect estimates. The second largest study (N = 120) was also judged by the authors of the 
systematic review to have high risk of bias (or it was noted that there was insufficient 
information to determine risk) across all of the specific domains they assessed (S9 Table).
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Figure 3: Causative effect estimates for maternal calcium on birth weight 
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Validity of the 25(OH)D and calcium genetic instruments 
The magnitude of the 25(OH)D SNPs association with maternal circulating 25(OH)D in 
ALSPAC was similar to the magnitudes reported in the source GWAS for five of the seven 
SNPs. There were differences for rs8018720 (which was weakly inversely, rather than 
positively associated with 25(OH)D in ALSPAC) and for rs117913124 (a weaker positive 
difference in ALSPAC when compared to source GWAS) (Table 3). Despite these 
differences, we found no evidence of heterogeneity between the Wald ratios and leave-one-
out analyses found no evidence of an outlier effect (see above).
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Table 3: 25(OH)D instruments effect on exposure in GWAS Source and ALSPAC 
SNP Nearby 
Genes 
Effect 
Allele  
Effect 
Allele 
Frequency 
(GWAS 
reported) 
GWAS No of 
Participants 
in GWAS 
Difference in mean 
25(OH)D per allele 
from GWAS, in 
natural logged (log) 
nmol/l (95% CI)  
No of 
Participants 
in ALSPAC 
Difference in mean 
25(OH)D per allele from 
ALSPAC, in log nmol/l 
(95% CI) 
rs3755967 GC C 0.72 Jiang et 
al[19] 
79,366 0.089 (0.084 to 0.094) 4,874 0.069 (0.048 to 0.091) 
rs117913124 CYP2R1 G 0.975 Manousaki 
et al[24] 
42,274 0.21 (0.19 to 0.23)* 4,874 0.079 (0.018 to 0.139) 
rs10741657 CYP2R1 A 0.4 Jiang et 
al[19] 
79,366 0.031 (0.027 to 0.035) 4,874 0.01 (-0.010 to 0.029) 
rs12785878 DHCR7 T 0.75 Jiang et 
al[19] 
79,366 0.036 (0.032 to 0.04) 4,874 0.049 (0.026 to 0.071) 
rs10745742 AMDHD1 T 0.41 Jiang et 
al[19] 
79,366 0.017 (0.013 to 0.021) 4,874 0.029 (0.009 to 0.049) 
rs8018720 SEC23A G 0.27 Jiang et 
al[19] 
79,366 0.017 (0.012 to 0.022) 4,874 -0.037 (-0.062 to -0.011) 
rs17216707 CYP24A1 T 0.79 Jiang et 
al[19] 
79,366 0.026 (0.021 to 0.031) 4,874 0.020 (-0.005 to 0.046) 
*This result differs from that reported by Manousaki et al. Their result was in units of standard deviations of 25(OH)D in log nmol/L. We 
converted that value to natural logged nmol/l by estimating the value of a standard deviation of log transformed nmol/L of 25(OH)D in the 
ALSPAC study.    
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Neither the 25(OH)D or the calcium genetic instrumental variable weighted allele scores 
were associated with observed confounders in the UKB, ALSPAC or EFSOCH, with the 
exceptions of maternal height, education and TDI. The score for 25(OH)D was negatively 
associated with height in the UKB, positively associated with height and negatively 
associated with TDI in EFSOCH and showed no association in ALSPAC; the score for 
calcium was negatively associated with educational level and positively associated with TDI 
in UKB (S10 Table). Given these findings, and on advice from one of the reviewers, we 
undertook further analyses, using multivariable MR[47], to explore whether maternal height 
might have masked a positive effect of 25(OH)D on BW (maternal height could be a masking 
confounder in these results as it is inversely associated with 25(OH)D but positively relates to 
BW) and whether maternal education confounded the MR effect estimate of maternal calcium 
on BW (further details available in S5 Text). Results from the multivariable IVW MR 
analyses were consistent with those from the unadjusted IVW MR analyses, for both the full 
adjustment of height for 25(OH)D-BW results and the partial maternal education calcium-
BW results (S11 Table). 
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Discussion 
This study triangulated two approaches (two-sample MR and instrumental variables applied 
to RCTs) assessing the effects of maternal circulating 25(OH)D and calcium on BW. Across 
the main, and all sensitivity, MR analyses we found no evidence that maternal 25(OH)D has 
an important effect on BW but applying instrumental variable analyses to RCTs there was 
evidence of a weak positive effect. Findings for maternal circulating calcium were 
inconsistent across methods and sensitivity analyses, making it difficult for us to conclude 
from the data used here what the effect of maternal circulating calcium on BW is. 
Whilst the instrumental variable applied to RCTs analyses for 25(OH)Ds effect suggested a 
weak positive effect of 5.94g (95% CI, 2.15 to 9.73, p=0.002) higher birth weight per 10% 
increase in 25(OH)D), this might be exaggerated by limitations of the original RCTs (S8 
Table and recent systematic review[16]) and is so small that it is unlikely to be of clinical or 
public health importance. Our MR analyses are largely in European origin populations 
whereas the RCTs were predominantly in South Asian or Middle Eastern populations and 
several were also in those with low 25(OH)D levels at the start of pregnancy. These 
population differences may also have contributed to differences between the two approaches, 
though it is notable that the RCTs suggest little evidence of an effect on birth weight even in 
these populations at high risk of vitamin D insufficiency. One of the proposed mechanisms 
underlying the hypothesis that maternal circulating 25(OH)D results in higher BW is by 
increasing offspring bone mineral density (BMD). However, a recent large, well conducted 
RCT found no evidence of an effect of maternal vitamin D3 supplementation on offspring 
neonatal BMD (assessed within 2 weeks of birth) [48]. When combined with our own 
findings there is, therefore, little evidence to suggest that maternal circulating 25(OH)D 
influences BW via increases in BMD. A recent MR study suggested no evidence of 
circulating 25(OH)D affecting the risk of pre-eclampsia[49], which is consistent with results 
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of a meta-analysis of RCTs of vitamin D supplementation on pre-eclampsia.[16] That same 
meta-analysis found no strong evidence that randomisation to vitamin D supplementation 
influenced gestational diabetes risk, when restricting analyses to trials with least risk of bias 
RCTs[16]. As pre-eclampsia and gestational diabetes affect BW [6], these findings are 
consistent with our results suggesting maternal 25(OH)D does not affect BW.  
It is possible that low circulating 25(OH)D levels are not a suitable indicator of vitamin D 
deficiency, as 1,25(OH)2D is the biologically active form of vitamin D and remains within 
reference limits even when circulating 25(OH)D levels are low, suggesting valid genetic and 
RCT instruments associated with 1,25(OH)2D levels could give different results. However, 
we are not aware of such instruments and circulating 25(OH)D has a longer half-life in the 
body, making it a more stable measurement and possibly a better indicator of long term 
vitamin D exposure[50]. Furthermore, previous observational studies that underpin the 
hypothesis that vitamin D levels are importantly related to BW, and a large number of other 
health outcomes, have used 25(OH)D as the marker of exposure.    
Although the main MR analyses did not support a causal effect of maternal calcium on 
offspring BW, sensitivity (MR-Egger and leave-one-out analyses) were not completely 
consistent with the main MR effect estimates and the instrumental variable analyses applied 
to RCTs were markedly different to any of the MR results. There are a number of possible 
reasons why we might have found these differences. The MR estimate may be biased by 
masking horizontal pleiotropy, which both our MR-Egger and leave one out analyses suggest. 
Thus, the MR-Egger effect estimate suggests a modest positive effect with wide confidence 
intervals and the leave one out analyses suggests that the heterogeneity between individual 
SNP Wald ratios is driven by one SNP rs1801725 which when removed results in an inverse 
association (again suggesting masking pleiotropy). Rs1801725 is in the CASR gene, which 
codes for the calcium-sensing receptor protein and is widely express in the parathyroid gland, 
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kidneys and intestines and regulated blood levels of calcium [51], whereas the other calcium 
SNPs are near to loci that are not known to have such a direct effect on calcium levels and 
may therefore be more prone to pleiotropy. The leave one out analyses, together with the 
Wald ratio result for CASR rs1801725 alone and the MR-Egger result all suggest that our 
main IVW results might be biased by masking horizontal pleiotropy and that there is a 
modest positive causal effect of calcium on BW. Possible sources of masking pleiotropy 
could be alterations to glucose levels, as one of the genetic instruments (rs780094) is 
associated with fasting glucose which is known to influence BW[52]. However, whilst these 
sensitivity analyses suggest a possible modest positive causal effect of maternal circulating 
calcium on BW, they have limited statistical power and therefore they are imprecisely 
estimated with wide confidence intervals. Importantly, whilst we were able to show most of 
the 25(OH)D SNPs related to pregnancy 25(OH)D, we were not able to assess this for 
maternal gestational calcium. If the calcium SNPs have weaker associations with circulating 
calcium levels in pregnancy (than they do in the GWAS of men [25]) this might bias towards 
the null any real effect of maternal pregnancy calcium on BW in our analyses. During 
pregnancy maternal circulating levels of calcium increase in order to support healthy skeletal 
development. This is achieved through increasing absorption from the intestines and through 
bone resorption in the mothers, but this process is, at least partially, under the control of the 
fetus, which increases the secretion of parathyroid hormone-related protein in response to low 
fetal plasma calcium [53]. Thus, fetal genetic variants might be important genetic instruments 
for MR analyses of maternal circulating gestational calcium’s effect on fetal skeletal 
development and hence BW.  
With respect to the difference between MR and instrumental variable analyses in RCT 
results, we might expect to see weaker effects from instrumental variable analyses in RCTs 
than from MR analyses as the former only tests differences in exposure from the time of 
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randomisation, whereas MR tests differences over most of life (and hence across all 
pregnancy trimesters). On-the-other-hand, for in utero exposures timing rather than duration 
of exposure might be important[20]. Though the fetus acquires all of its calcium from the 
mother throughout pregnancy, some evidence suggests that 80% of calcium in a neonates 
bones are absorbed during the third trimester (possibly due to an increase in maternal 1,25-
dihydroxyvitamin D levels in the third trimester) [54], which would mean that 
supplementation starting earlier in pregnancy and continuing through to delivery might be 
necessary to ensure adequate levels for bone development throughout the third trimester (and 
hence an effect on BW). Five of the six RCTs that we included in our analyses would fit with 
this, as supplementation began at or before 23 weeks of gestation and continued until delivery 
(the one study which start supplementation in the third trimester 28 to 31 weeks only 
included 32 participants). Overall, we might then expect the RCT and MR results to be 
similar. However, the results from the instrumental variable analyses in RCTs might be 
biased due to the inclusion of only six calcium supplementation RCTs, with the two largest 
ones having important sources of bias (S9 Table). Furthermore, whilst our MR analyses are 
largely in European origin populations, the RCTs were predominantly in non-European 
populations, in particular Latin American populations, which may explain some of the 
differences.  
Study Strengths and Limitations 
To the best of our knowledge, this is the first study to compare results from MR and 
instrumental variable analyses applied to RCTs to investigate the effect of maternal 
circulating calcium levels on offspring BW. The GWAS that we used for genetic instrument-
exposure associations (sample 1) in our two sample MR did not provide the percentage 
variation in calcium that all seven SNPs explained. However, based on a previous study that 
provided the R2 for one of these seven SNPs (rs1801725)[55] we know that our instrument 
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with all seven SNPs will explain at least 2% of the variation in circulating calcium. We have 
considerably increased the sample size of our previous MR study of the effect of maternal 
circulating 25(OH)D on offspring BW[6]. These additions have increased the strength of our 
instrument, with the R2 in our study suggesting the genetic variants explained ~3% of 
variation in circulating 25(OH)D compared with <1% of the variation explained by the two 
SNPs used in the previous MR study[6].We have explored the validity of our genetic 
instrumental variables using multiple sensitivity analyses and compared those results with 
instrumental variable analyses applied to RCTs, in which summary results from the RCTs 
were extracted independently by two people and checked for consistency with a third. 
Key potential limitations include the low response to UKB and maternal-report of first child’s 
BW many years after their birth. Recent research suggests that a highly select cohort (as in 
the case of UKB with a 5% response [56] ) can result in selection bias in genetic or MR 
analyses [57,58]. Self-report of BW and the rounding to 1 pound (~0.454kg) may have 
introduced error in the BW measure in UKB, but this would be random with respect to 
genotype and expected to bias results towards the null. The somewhat lower mean BW in 
UKB participants than ALSPAC/EFSOCH is likely to reflect secular trends of increasing 
birth size over time the fact that they reported only the weight of first-born children, whereas 
in ALSPAC/EFSOCH index children are from any pregnancy. The ALSPAC/EFSOCH MR 
estimates were stronger than the UKB estimates, though with very wide confidence intervals 
reflecting their smaller sample size and there is no evidence that the results were statistically 
inconsistent with those from UKB. These two cohorts were used in sensitivity analyses to 
explore whether the main MR analyses might be biased by a path from maternal genotype via 
fetal genotype to their BW. We have shown this is not the case. However, adjustment for 
fetal genotype could introduce a spurious association between maternal and paternal 
genotype[44], and if fathers circulating 25(OH)D or calcium influenced offspring BW this 
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could bias our results. As it is unlikely that fathers circulating levels of 25(OH)D or calcium 
could directly influence fetal growth and offspring BW we feel our offspring adjusted results 
are unlikely to be biased. This is also supported by the lack of any effect of own 25(OH)D or 
calcium on own BW in MR sensitivity analyses in UKB.  
In UKB the 25(OH)D genetic risk score was negatively associated with height, and as it is 
possible that greater maternal height results in greater BW, independently of the offspring 
genotype[59], this could mask any true positive effect of 25(OH)D on BW. We also found 
that the calcium genetic instrument was associated with markers of socioeconomic position 
(area deprivation and education), which could confound the MR estimated effect of calcium 
on BW. However, results of multivariable MR adjusting the maternal 25(OH)D effect on BW 
for maternal height and the maternal calcium effect on BW (partially) for maternal education 
were consistent with the unadjusted results, suggesting that our results were not importantly 
confounded. 
Horizontal pleiotropy is a key source of bias for MR studies. For the effects of maternal 
circulating 25(OH)D on BW the consistency of results across all of our MR analyses suggest 
that has not been a key source of bias in for that exposure. We did find evidence of potential 
horizontal pleiotropy with maternal calcium effects and as discussed above, and acknowledge 
that further studies are required to explore that effect. We have assumed that genetic variants 
that relate to 25(OH)D/calcium in (non-pregnant) women and men have the same magnitudes 
of association with these exposures in pregnant women. We were unable to test this for 
calcium but did show that five out of the seven variants related similarly to circulating 
25(OH)D during pregnancy as in the GWAS. Removal of either of the two that did not 
associate as strongly to 25(OH)D in pregnancy in our leave-one-out analyses were consistent 
with the main results and all other leave-one-out analyses. Although we aimed to use 
randomisation to use supplementation with vitamin D or calcium as an instrumental variable 
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for RCTs, some studies did not provide results from intention to treat analyses. Therefore, 
results from these studies could be biased by non-compliance. The aim of triangulation is to 
compare results from different methods that have different key sources of bias. Whilst both 
approaches that we have used here rely on instrumental variables and have the same 
underlying assumptions, the sources of violation of these assumptions differ between MR and 
instrumental variables applied to RCTs. For MR, horizontal pleiotropy is the key source of 
bias, whereas for instrumental variables applied to RCT, it is lack of concealed random 
allocation (which can introduce bias) and not using intention to treat analysis (which can 
produce a path from the instrument to outcome and/or introduce confounding). The fact that 
there was no marked difference between our MR and RCT analyses strengthen confidence in 
the findings for 25(OH)D. However, as discussed above, the different results for calcium 
need further exploration. In both our two sample MR and instrumental variable analyses 
applied to RCTs we have used summary data and are unable to explore possible non-linear 
effects, though observational studies do not suggest that these are present. Similarly, we 
cannot explore effect modification, but we are not aware of any evidence that the effects that 
we have looked at do differ by other characteristics. Our MR analyses are in white European 
populations and may not generalise to other groups, such as those with different levels of skin 
pigmentation and exposures to sunshine. However, most of the RCTs for vitamin D and 
calcium supplementation are in non-Europeans. In particular most vitamin D RCTs were in 
Middle Eastern or South Asian populations and a recent RCT in Bangladesh, which was not 
included in the systematic review that we used in this paper for the RCT analyses, found that 
vitamin D supplementation during pregnancy made no difference to BW [60]. Thus even in a 
low-income, dark skinned population, maternal circulating 25(OH)D  may not be an 
important factor in BW. 
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In conclusion, our results suggest that maternal circulating 25(OH)D does not have a 
clinically important effect on BW., so pregnancy supplementation with vitamin D is unlikely 
to affect mean BW. Higher maternal circulating calcium may increase BW, but further 
research is required to clarify this, including larger samples for undertaking pleiotropy 
‘adjusted’ MR analyses and larger better conducted RCTs of calcium supplementation.  
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